Building Blocks; Pharmaceutical/API Drug Impurities/Metabolites;
應用
5-Bromo-2-chlorobenzoic acid is used as a starting material in the synthesis of Dapagliflozin (D185370), a selective sodium-glucose cotransporter-2 inhibitor that reduces renal glucose reabsorption and is used to treat patients with type 2 diabetes.
參考文獻
List, J., et al.: Diabetes Care, 32, 650 (2009); Meng, W., et al.: J. Med. Chem., 51, 1145 (2008); Wilding, J., et al.: Diabetes Care, 32, 1656 (2009)
滬ICP備17019645號
400-821-0725
